| Product Name | CDE状态 |
| Abiraterone Acetate | A |
| Afatinib Maleate | A |
| Bortezomib | A |
| Capecitabine | A |
| Carfilzomib | A |
| Erlotinib | A |
| Gemcitabine Hydrochloride | A |
| lrinotecan Hydrochloride | A |
| Neratinib Maleate | A |
| Nilotinib | A |
| Paclitaxel | A |
| Palbociclib | A |
| Pazopanib | A |
| Pemetrexed Disodium | A |
| Regorafenib | A |
| Sorafenib Tosylate | A |
| Apalutamide | I |
| Abemaciclib | I |
| Cabazitaxel | I |
| Gefitinib | I |
| lbrutinib | I |
| Product Name | DME |
| Abemaciclib | DMF |
| Abiraterone Acetate | EDMF/J-MF |
| Afatinib Maleate | EDMF |
| Alectinib | DMF |
| Bortezomib | DMF |
| Cabazitaxel | US DMF |
| Capecitabine | USDMF/CEP |
| Carfilzomib | USDMF |
| Capivasertib | DMF |
| Dasatinib | EDMF/J-MF |
| Docetaxel | DMF |
| Enzalutamide | EDMF |
| Erlotinib | EDMF |
| Gefitinib | EDMF |
| Gemcitabine Hydrochloride | DMF |
| lbrutinib | DMF |
| Imatinib Mesylate | USDMF/CEP |
| lrinotecan Hydrochloride | CEP |
| Lapatinib | EDMF |
| Lenvatinib Mesylate | DMF |
| Neratinib Maleate | DMF |
| Nilotinib | EDMF |
| Nintedanib | DMF |
| Paclitaxel | DMF |
| Palbociclib | USDMF/EDMF |
| Pazopanib | USDMF/EDMF |
| Pemetrexed Disodium | USDMF/CEP |
| Regorafenib | DMF |
| Ribociclib | DMF |
| Rucaparib | DMF |
| Sorafenib Tosylate | EDMF |
| Sunitinib | EDMF |
| Venetoclax | DMF |
| Acalabrutinib | DMF |
| Apalutamide | DMF |
| Alpelisib | TIP |
| Elacestrant | TIP |
| In house | TIP |
| Darolutamide | TIP |
| Encorafenib | TIP |
| Lorlatinib | TIP |
| Niraparib | TIP |
| Relugolix | TIP |
| Savolitinib | TIP |
| Tepotinib | TIP |
| Tucatinib | TIP |
| Vemurafenib | TIP |
| Momelotinib Hydrochloride | TIP |
